Physician profile
Jacob A Quick
NPI 1649431941
$12,415.15
in general payments reported to CMS, 2019-2025
23 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $28.09 · 2021: $445 · 2022: $9,401 · 2023: $1,760 · 2024: $398 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,301 · Travel and Lodging: $1,035 · Gift: $16.25 · Education: $14.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,300.92 |
| Travel and Lodging | $1,034.88 |
| Gift | $16.25 |
| Education | $14.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,212.44 | 2022-2024 | Da Vinci Surgical System, Da Vinci Sp |
| Baxter Healthcare | $931.57 | 2021-2024 | Renal - Pd |
| Ethicon US, LLC | $262.17 | 2019-2022 | |
| Smith+Nephew, INC. | $169.85 | 2023-2025 | Collagenase Santyl |
| Medtronic, INC. | $168.73 | 2022-2023 | Signia, Ligasure |
| Convatec INC. | $103.86 | 2023-2024 | |
| W. L. Gore & Associates, INC. | $82.33 | 2023-2024 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Vertex Pharmaceuticals Incorporated | $80.27 | 2024-2025 | |
| Mozarc Medical US LLC | $65.17 | 2024 | Argyle |
| Polynovo North America LLC | $43.01 | 2024 | Novosorb Btm |
| Davol INC. | $39.62 | 2023-2025 | Phasix Mesh |
| Kerecis Limited | $37.56 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Pacira Pharmaceuticals Incorporated | $35.08 | 2025 | Exparel |
| Acera Surgical, INC. | $26.59 | 2022 | |
| Solventum Corporation | $23.74 | 2025 | Prevena, V.A.C. Veraflo |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $21.35 | 2022 | |
| Lifenet Health | $21.13 | 2025 | Theragenesis Wound Matrix |
| Becton, Dickinson and Company | $20.01 | 2024 | Phasix Mesh |
| Z-Medica, LLC | $18.99 | 2019 | |
| Organogenesis INC. | $18.46 | 2023 | Puraply |
| Hospira, INC. | $16.85 | 2023 | |
| Conmed Corporation | $16.37 | 2025 | Visiclear |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Quick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.